PMA device
NuDel Delivery System
NuMED, Inc. · Aortic Stent (PNF, Class III) · First FDA decision Nov 14, 2018, newest Nov 14, 2018Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "NuDel"
MAUDE reports
0
Brand "NuDel", since 2015
PubMed studies
90
Mentioning "NuDel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NuDel Delivery System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NuDel", any status and sponsor, newest update first.
No registered device study names "NuDel".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NuDel", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PNF
92 reports: 73 malfunction, 18 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NuDel"[tiab]. The summary above synthesizes these.
- Nudel involvement in the high-glucose-induced epithelial-mesenchymal transition of tubular epithelial cells.
Zhang W, Xing L, Xu L, et al. · Am J Physiol Renal Physiol · 2019Research Support, Non-U.S. Gov't
- Expression of NUDEL in manchette and its implication in spermatogenesis.
Yamaguchi N, Takanezawa Y, Koizumi H, et al. · FEBS Lett · 2004
- Neuronal migration.
Lambert de Rouvroit C, Goffinet AM · Mech Dev · 2001Research Support, Non-U.S. Gov't, Review
- The maternal nudel protein of Drosophila has two distinct roles important for embryogenesis.
Hong CC, Hashimoto C · Genetics · 1996Research Support, U.S. Gov't, P.H.S.
- Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells.
Shen Y, Li N, Wu S, et al. · Dev Cell · 2008Research Support, Non-U.S. Gov't
- A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system.
Sasaki S, Shionoya A, Ishida M, et al. · Neuron · 2000Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1.
Hayashi MA, Portaro FC, Bastos MF, et al. · Proc Natl Acad Sci U S A · 2005Research Support, Non-U.S. Gov't
- A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons.
Nguyen MD, Shu T, Sanada K, et al. · Nat Cell Biol · 2004Research Support, Non-U.S. Gov't
- Nudel modulates kinetochore association and function of cytoplasmic dynein in M phase.
Liang Y, Yu W, Li Y, et al. · Mol Biol Cell · 2007Research Support, Non-U.S. Gov't
- Nudel functions in membrane traffic mainly through association with Lis1 and cytoplasmic dynein.
Liang Y, Yu W, Li Y, et al. · J Cell Biol · 2004Research Support, Non-U.S. Gov't
- Nudel promotes axonal lysosome clearance and endo-lysosome formation via dynein-mediated transport.
Zhang Q, Wang F, Cao J, et al. · Traffic · 2009Research Support, Non-U.S. Gov't
- Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin.
Shan Y, Yu L, Li Y, et al. · PLoS Biol · 2009Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code PNF.
- Minima Stent SystemRenata Medical, Inc. · PMA 2026
- Cheatham Platinum (CP) Stent System (Covered CP StentNuMED, Inc. · PMA 2017
- Minima Pro Stent SystemRenata Medical, Inc. · PMA 2026
- CP Stent (Model 425)NuMED, Inc. · PMA 2026
- G-Armor StentNuMED, Inc. · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.